Curated By Isabella Tang
Typhoon Bavi has led to the evacuation of over 260,000 residents in several provinces of China due to severe flooding. Authorities are working tirelessly to manage the impact of the storm and provide assistance to affected communities.
Typhoon Bavi has caused widespread flooding across several provinces in Mainland China, leading to the evacuation of over 260,000 residents. Authorities are on high alert as the storm continues to impact the region with heavy rainfall and strong winds.
A devastating fire at a factory in China has resulted in the deaths of at least 28 people, with many others injured. The incident has raised concerns over safety regulations and emergency response protocols in the industrial sector.
Chinese President Xi Jinping has expressed deep sorrow over the tragic fire incident at a shoe factory in China that resulted in significant loss of life. The blaze has raised concerns about workplace safety regulations and emergency response protocols in the manufacturing sector.
Former Vice President Mike Pence commended Donald Trump for his role in securing the release of Pastor Ezra Jin, a prominent figure in the Beijing Zion Church, from Chinese authorities. This development highlights ongoing tensions between the U.S. and China over religious freedoms and human rights.
InnoCare has announced the first patient has been dosed in its clinical trial for ICP-B208, a novel CDH17 targeted antibody-drug conjugate. This marks a significant milestone in the development of targeted therapies for cancer treatment in Mainland China.
In a significant diplomatic development, China has released a prominent pastor two months after former President Trump publicly called for his release during a meeting with President Xi Jinping. This event highlights the complexities of U.S.-China relations and the ongoing issues surrounding religious freedom in China.
Pastor Ezra Jin Mingri has been released from prison in China just weeks after former President Donald Trump called for his release. The pastor's case highlights ongoing concerns regarding religious freedom in the country.
A prominent Chinese pastor has been released from prison after former President Donald Trump raised his case with Chinese President Xi Jinping. This development highlights ongoing tensions surrounding religious freedom in China and the influence of international diplomacy.
HUTCHMED has announced that its drug ORPATHYS® has received approval from the National Medical Products Administration (NMPA) in China for the treatment of gastric cancer patients with MET amplification. This milestone marks a significant advancement in targeted therapies for a challenging cancer type prevalent in the region.
Shenzhen has transformed from a small fishing village into a bustling metropolis and a global technology powerhouse in just over four decades. This rapid growth has attracted major companies and millions of residents, reshaping the region's economic landscape.
Hua Hong Grace, a leading China-based specialty foundry, is making significant strides in semiconductor manufacturing with its 40nm low-power process technology. The company is also ramping up production at its Wuxi 12-inch facility, positioning itself as a key player in the global semiconductor industry.
He Mingke, CEO of Ping An Good Doctor, addressed the growing significance of health technology in China's aging population at the 2026 Summer Davos. He emphasized the need for innovative healthcare solutions as the country enters its 'Longevity Era'.
In a significant move to tighten capital controls, China International Capital Corp has restricted new cross-border swaps, signaling Beijing's ongoing efforts to manage currency fluctuations and capital outflows. This decision reflects the government's focus on maintaining financial stability amid economic uncertainties.
In a significant move to enhance the international use of the yuan, China has allowed six banks to conduct offshore yuan transactions directly from the mainland. This development marks a pivotal step in China's efforts to promote its currency in global markets.
CityUHK (Dongguan) held its inaugural commencement ceremony for the Class of 2026, marking a significant milestone in the university's mission to foster academic excellence. The event featured esteemed speakers and highlighted the achievements of its first graduating cohort.
China is increasingly leveraging artificial intelligence technologies for undersea exploration and resource extraction. This strategic move aims to enhance its maritime capabilities and assert its dominance in the global AI landscape.
Ping An Good Doctor has announced an upgrade to its AI Doctor service, aiming to improve healthcare accessibility for its vast user base. The enhanced service will leverage artificial intelligence to provide more efficient medical consultations to millions of users in China.
China's retail sales have seen a significant decline for the first time since the COVID-19 lockdowns, raising concerns about the country's economic recovery. Analysts are closely monitoring the implications of this downturn on consumer confidence and overall economic growth.
Akeso has announced the enrollment of the first patient in a Phase Ib/II clinical trial evaluating its next-generation HER3 antibody-drug conjugate AK138D1 in combination with Ivonescimab for breast cancer treatment. This study represents a significant advancement in the company's IO2.0 + ADC2.0 strategy, aiming to improve therapeutic outcomes for patients.
iFLYTEK has launched its innovative SpaceMind technology, which integrates artificial intelligence with the physical world. This groundbreaking development promises to enhance human-computer interaction and revolutionize various industries.
China has inaugurated its first photonic computing laboratory, marking a significant step in its technological advancements amid ongoing chip restrictions from the United States. This initiative aims to leverage light-based computing to enhance processing power and efficiency in various applications.
China has raised alarms about the risk of extreme flooding in its desert areas, as heavy rainfall is expected to impact these typically arid regions. Authorities are urging residents to prepare for potential natural disasters amid changing climate patterns.
Akeso, a leading biopharmaceutical company, has received approval from the National Medical Products Administration (NMPA) for its innovative drug Gumokimab (AK111) to treat moderate-to-severe plaque psoriasis. This milestone enhances Akeso's portfolio in autoimmune diseases, marking a significant advancement in patient care in China.
